Magnesium Forms Compared: Glycinate vs Oxide vs Citrate vs L-Threonate

A thorough magnesium forms comparison reveals a landscape more complicated than the supplement aisle suggests. Walk into any health food store and you will find magnesium oxide, citrate, glycinate, malate, taurate, L-threonate, orotate, and more — often with vague claims attached to each. These forms are not interchangeable. They differ substantially in how much elemental magnesium they deliver, how efficiently that magnesium is absorbed in the gut, which tissues it preferentially enters, and what side effects it causes along the way. Choosing the wrong form means either wasting money, tolerating unnecessary side effects, or failing to address the specific magnesium-sensitive process you care about most. This article provides a clear side-by-side breakdown based on the current evidence.

The Evidence Base: How Bioavailability Is Measured

Magnesium bioavailability is typically measured via isotope tracing (stable isotope studies), urinary excretion after loading dose, or serum/red blood cell magnesium levels. Each method has limitations: serum magnesium is tightly regulated and poorly reflects total body stores (Gröber et al., 2015), urinary excretion reflects absorbed fraction but not tissue retention, and isotope studies are expensive and not available for all forms.

Not all magnesium supplements are equal — the table below compares the most common forms by bioavailability and best use case:

Form	Elemental Mg %	Bioavailability	Best Use Case	Notes
Magnesium Oxide	~60%	Low (~4%)	Short-term constipation relief	Most common, least absorbed
Magnesium Citrate	~16%	Moderate–High	General supplementation, regularity	Good balance of cost and absorption
Magnesium Glycinate	~14%	High	Sleep, anxiety, sensitive stomach	Chelated; minimal laxative effect
Magnesium Malate	~15%	Moderate–High	Energy, muscle fatigue	Malic acid supports ATP production
Magnesium Threonate	~8%	High (CNS)	Cognitive support, brain Mg levels	Crosses blood-brain barrier more readily
Magnesium Taurate	~9%	Moderate	Cardiovascular, blood pressure	Taurine adds heart-supportive effects

Schwalfenberg and Genuis (2017) reviewed clinical uses of magnesium across forms and noted that inorganic salts (oxide, sulfate) show substantially lower bioavailability than organic chelates (glycinate, malate, citrate). A 2001 comparison study (Firoz and Graber) found that magnesium citrate was absorbed approximately 30% better than magnesium oxide. More recent data from Abbasi et al. (2012) in elderly subjects used magnesium oxide specifically and still found significant improvement in sleep quality — partly because the population was severely magnesium-deficient, meaning even a poorly absorbed form provided functional benefit. The practical lesson: bioavailability matters less in profound deficiency and more in people who are borderline deficient or supplementing for optimization.

As covered in our Magnesium Deficiency Signs guide, deficiency is more widespread than standard blood tests detect — approximately 45–60% of Americans consume below the RDA, making form selection practically important for most supplementers.

The Mechanism: Why Chelation Matters

The central factor distinguishing high-bioavailability from low-bioavailability forms is whether the magnesium is chelated — meaning bonded to an organic ligand — versus existing as an inorganic salt. Inorganic magnesium salts (oxide, carbonate, sulfate) dissociate quickly in the gut, releasing free Mg²⁺ ions that depend on passive paracellular absorption and are sensitive to competing minerals (calcium, zinc) and intestinal pH. At high doses, they exceed the gut’s absorptive capacity, drawing water into the colon osmotically and causing the loose stools for which magnesium oxide is notorious.

Organic chelates bond magnesium to an amino acid or organic acid ligand. This protects the magnesium ion during transit through the acidic stomach, allows it to be transported via amino acid carriers (active transport), and delivers it further into the small intestine where absorption efficiency is higher. Glycinate chelates additionally benefit from the fact that glycine itself has calming effects on the CNS, creating a synergy that makes magnesium glycinate particularly effective for sleep and anxiety applications. The chelate also reaches systemic circulation at higher rates — meaning more of what you swallow ends up where you need it.

Magnesium Oxide: High Elemental Content, Low Absorption

Magnesium oxide contains approximately 60% elemental magnesium by weight — the highest of any form, which is why cheap supplements often lead with it. The problem is bioavailability: human studies estimate absorption rates of 4–14%, meaning a 400 mg magnesium oxide capsule may deliver only 16–56 mg of absorbable magnesium. By comparison, magnesium glycinate at 20% elemental content but 80%+ absorption efficiency may deliver more usable magnesium from a smaller listed dose.

Magnesium oxide’s main redeeming quality is its use as a laxative. The unabsorbed magnesium draws water into the colon, producing a reliable osmotic laxative effect at doses of 400–800 mg. For constipation, this is useful. For any other application — sleep, muscle function, anxiety, blood pressure — the poorly absorbed magnesium mostly travels through without contributing meaningfully to tissue levels. Magnesium oxide is not recommended as a primary supplementation form for general health purposes. As our detailed Magnesium Glycinate Guide explains, the difference in practical efficacy between oxide and glycinate is substantial and clinically meaningful.

Magnesium Citrate: Widely Used, Reasonably Effective

Magnesium citrate is the most commonly sold form globally. It contains approximately 16% elemental magnesium by weight and shows substantially better bioavailability than oxide — roughly 25–30% absorbed in human studies, and better tolerability at moderate doses. At higher doses (above 400 mg elemental magnesium), citrate still has a laxative effect, though less pronounced than oxide. This can be an advantage or disadvantage depending on the user’s situation.

Citrate is a reasonable choice for general magnesium repletion in deficient individuals. The accompanying citrate anion participates in the TCA cycle, and citrate is a urinary alkalinizer — making this form potentially useful for kidney stone prevention in patients with calcium oxalate stones. Zhang et al. (2016) studied magnesium supplementation and blood pressure in a meta-analysis and found a statistically significant reduction — the included studies used mixed forms, but citrate was among the most common. For general supplementation without specific sleep or cognitive goals, citrate offers a reasonable cost-to-absorption tradeoff.

Magnesium Glycinate: The Standard for General Use

Magnesium glycinate (also sold as magnesium bisglycinate) is widely considered the best general-purpose supplemental form. Glycine is a non-essential amino acid that acts as an inhibitory neurotransmitter in the central nervous system, binding to both glycine receptors and NMDA receptors. This adds a calming, anxiolytic component to supplementation that pure magnesium alone does not provide. The combination makes glycinate particularly effective for sleep onset, anxiety reduction, and stress resilience — outcomes that align with the GABA-enhancing effects of both magnesium itself (which modulates GABA receptors) and glycine.

Bioavailability studies consistently rank glycinate among the top forms. Gröber et al. (2015) noted that amino acid chelates of magnesium achieve higher plasma and tissue levels per gram supplemented than comparable inorganic salts. Importantly, magnesium glycinate is gentle on the gastrointestinal tract — it can be taken at doses of 300–600 mg elemental magnesium per day without the laxative effects common with oxide or citrate. For most adults supplementing for sleep quality, muscle recovery, anxiety management, or general magnesium repletion, glycinate is the form with the strongest evidence-to-tolerance profile. Bio:sudo Magnesium Glycinate delivers 300 mg elemental magnesium per serving as a high-absorption chelate, consistent with effective doses used in clinical trials like Abbasi et al. (2012).

For a deeper comparison of glycinate against the cognitive formulation threonate, see our Magnesium Glycinate vs Threonate breakdown.

Magnesium L-Threonate: The Cognitive Formulation

Magnesium L-threonate is a newer, patented form (marketed as Magtein) developed specifically to cross the blood-brain barrier and raise brain magnesium concentrations. The threonate ligand acts as a carrier that facilitates transport across the BBB via active transport mechanisms that do not apply to other magnesium chelates. Preclinical studies in rodents showed significantly higher cerebrospinal fluid magnesium levels with threonate versus glycinate or citrate, along with improvements in synaptic plasticity, learning, and memory.

Human data is more limited. A 12-week trial in cognitively normal adults aged 51–70 found improvements in overall cognitive composite score and executive function with magnesium L-threonate supplementation (Liu et al., 2016). The effect sizes were modest and the sample was small (N=44). Longer and larger trials are needed. The elemental magnesium content of threonate is approximately 7–8% by weight, meaning a standard dose provides relatively little total body magnesium — this form is designed for brain delivery, not general magnesium repletion. For someone with widespread magnesium deficiency, glycinate is a better starting point; for someone with adequate total body magnesium who has specific cognitive goals, adding threonate makes mechanistic sense.

Other Notable Forms

Magnesium malate is chelated with malic acid, a TCA cycle intermediate involved in ATP production. It is commonly recommended for fibromyalgia and chronic fatigue conditions based on the hypothesis that malic acid deficiency underlies mitochondrial dysfunction in these conditions. A small randomized trial (Russell et al., 1995) found symptom improvement in fibromyalgia with magnesium malate supplementation, though the study quality was limited. For people with fatigue-dominant presentations, malate has a plausible mechanism worth considering.

Magnesium taurate is chelated with taurine, an amino acid with cardiac and neurological functions. The combination has been studied for blood pressure and cardiac rhythm applications — Veronese et al. (2021) reviewed oxidative stress effects of magnesium supplementation broadly, and taurate’s cardiovascular synergy (taurine independently supports cardiac electrophysiology and blood pressure) makes it of interest for cardiovascular health applications. Evidence is less robust than for glycinate or citrate.

Magnesium orotate is chelated with orotic acid, which participates in pyrimidine biosynthesis. It has been studied in heart failure (Stepura and Martynow, 2009, found improved outcomes in NYHA Class II–IV heart failure with magnesium orotate supplementation). This is a specialized clinical application; for general use, orotate offers no demonstrated advantage over glycinate or citrate.

Who Benefits Most from Each Form

• Magnesium glycinate: Sleep problems, anxiety, stress, general deficiency repletion, muscle cramps. Best default form for most adults. Well-tolerated at effective doses.
• Magnesium citrate: General deficiency, occasional constipation, kidney stone prevention. Good budget option when GI tolerance is not an issue at lower doses.
• Magnesium L-threonate: Cognitive optimization, age-related memory concerns, in addition to another form for full-body repletion. Not suitable as a primary magnesium source due to low elemental content.
• Magnesium malate: Fibromyalgia, chronic fatigue, mitochondrial support goals. Reasonable choice when fatigue and muscle pain dominate the clinical picture.
• Magnesium oxide: Constipation relief. Not recommended for general magnesium supplementation due to poor bioavailability.
• Magnesium taurate: Cardiovascular health, blood pressure support. Limited but plausible evidence base for this specific goal.

Practical Takeaways

• Form matters enormously: magnesium oxide is 4–14% absorbed; magnesium glycinate can reach 80%+ absorption — you are getting fundamentally different amounts of bioavailable magnesium from the same listed dose.
• For most adults supplementing for sleep, muscle function, anxiety, or general deficiency correction, magnesium glycinate is the form with the strongest evidence-to-tolerability profile and should be the default choice.
• Magnesium L-threonate is the only form with data supporting brain magnesium elevation and cognitive effects — but its low elemental magnesium content means it should be used alongside, not instead of, a systemic form like glycinate.
• Effective doses of elemental magnesium in clinical trials are typically 200–400 mg/day; read supplement labels carefully to distinguish the total compound weight from the elemental magnesium content.
• Time your magnesium glycinate dose in the evening — the glycine component has sedative effects that are best leveraged 1–2 hours before sleep.
• If you experience loose stools with any magnesium form, switch to glycinate or reduce your dose; the laxative effect signals dose-dependent non-absorption, not a useful side effect.

Bottom Line

Not all magnesium is created equal. Magnesium oxide dominates the market because it is cheap to manufacture and has a high listed elemental content — but its poor bioavailability makes it an ineffective choice for general supplementation. Magnesium glycinate and citrate offer substantially better bioavailability and tolerability, with glycinate being preferable for sleep, anxiety, and muscle applications. Magnesium L-threonate is the only form with evidence for brain-specific delivery but should supplement, not replace, a general form. Match the form to the goal, read the elemental magnesium content, and dose in the evening for glycinate if sleep is the primary target.

References

1. Schwalfenberg GK, Genuis SJ. “The importance of magnesium in clinical healthcare.” Scientifica. 2017;2017:4179326. [Source]
2. Abbasi B, et al. “The effect of magnesium supplementation on primary insomnia in elderly.” J Res Med Sci. 2012;17(12):1161–1169. [Source]
3. Gröber U, et al. “Magnesium in prevention and therapy.” Nutrients. 2015;7(9):8199–8226. [Source]
4. Zhang X, et al. “Effects of magnesium supplementation on blood pressure: a meta-analysis of randomized double-blind placebo-controlled trials.” Hypertension. 2016;68(2):324–333. [Source]
5. Veronese N, et al. “Effect of magnesium supplementation on oxidative stress in humans: a systematic review.” Eur J Nutr. 2021;60(4):2049–2063. [Source]

---

---